The use of preoperative radiotherapy in the management of patients with clinically resectable rectal cancer: a practice guideline
- PMID: 14633275
- PMCID: PMC281590
- DOI: 10.1186/1741-7015-1-1
The use of preoperative radiotherapy in the management of patients with clinically resectable rectal cancer: a practice guideline
Abstract
Background: This systematic review with meta-analysis was designed to evaluate the literature and to develop recommendations regarding the use of preoperative radiotherapy in the management of patients with resectable rectal cancer.
Methods: The MEDLINE, CANCERLIT and Cochrane Library databases, and abstracts published in the annual proceedings of the American Society of Clinical Oncology and the American Society for Therapeutic Radiology and Oncology were systematically searched for evidence. Relevant reports were reviewed by four members of the Gastrointestinal Cancer Disease Site Group and the references from these reports were searched for additional trials. External review by Ontario practitioners was obtained through a mailed survey. Final approval of the practice guideline report was obtained from the Practice Guidelines Coordinating Committee.
Results: Two meta-analyses of preoperative radiotherapy versus surgery alone, nineteen trials that compared preoperative radiotherapy plus surgery to surgery alone, and five trials that compared preoperative radiotherapy to alternative treatments were obtained. Randomized trials demonstrate that preoperative radiotherapy followed by surgery is significantly more effective than surgery alone in preventing local recurrence in patients with resectable rectal cancer and it may also improve survival. A single trial, using surgery with total mesorectal excision, has shown similar benefits in local recurrence.
Conclusion: For adult patients with clinically resectable rectal cancer we conclude that: Preoperative radiotherapy is an acceptable alternative to the previous practice of postoperative radiotherapy for patients with stage II and III resectable rectal cancer. Both preoperative and postoperative radiotherapy decrease local recurrence but neither improves survival as much as postoperative radiotherapy combined with chemotherapy. Therefore, if preoperative radiotherapy is used, chemotherapy should be added postoperatively to at least patients with stage III disease.
Figures





Similar articles
-
A systematic overview of radiation therapy effects in rectal cancer.Acta Oncol. 2003;42(5-6):476-92. doi: 10.1080/02841860310012301. Acta Oncol. 2003. PMID: 14596508
-
Preoperative chemotherapy for resectable thoracic esophageal cancer.Cochrane Database Syst Rev. 2001;(1):CD001556. doi: 10.1002/14651858.CD001556. Cochrane Database Syst Rev. 2001. Update in: Cochrane Database Syst Rev. 2003;(4):CD001556. doi: 10.1002/14651858.CD001556. PMID: 11279723 Updated.
-
Neoadjuvant or adjuvant therapy for resectable gastric cancer? A practice guideline.Can J Surg. 2002 Dec;45(6):438-46. Can J Surg. 2002. PMID: 12500920 Free PMC article.
-
Follow-up of patients with curatively resected colorectal cancer: a practice guideline.BMC Cancer. 2003 Oct 6;3:26. doi: 10.1186/1471-2407-3-26. BMC Cancer. 2003. PMID: 14529575 Free PMC article.
-
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320. Health Technol Assess. 2001. PMID: 12065068
Cited by
-
MAP17 (PDZK1IP1) and pH2AX are potential predictive biomarkers for rectal cancer treatment efficacy.Oncotarget. 2018 Aug 31;9(68):32958-32971. doi: 10.18632/oncotarget.26010. eCollection 2018 Aug 31. Oncotarget. 2018. PMID: 30250642 Free PMC article.
-
Update on advances and controversy in rectal cancer treatment.Tech Coloproctol. 2016 Mar;20(3):145-52. doi: 10.1007/s10151-015-1418-y. Epub 2016 Jan 12. Tech Coloproctol. 2016. PMID: 26754651 Review.
-
Inequity in access to guideline-recommended colorectal cancer treatment in Nova Scotia, Canada.Healthc Policy. 2012 Nov;8(2):71-87. Healthc Policy. 2012. PMID: 23968617 Free PMC article.
-
Neoadjuvant chemoradiation for rectal cancer reduces lymph node harvest in proctectomy specimens.J Gastrointest Surg. 2009 Feb;13(2):269-74. doi: 10.1007/s11605-008-0717-2. Epub 2008 Oct 11. J Gastrointest Surg. 2009. PMID: 18850250
-
Preoperative radiotherapy and curative surgery for the management of localised rectal carcinoma.Cochrane Database Syst Rev. 2018 Oct 3;10(10):CD002102. doi: 10.1002/14651858.CD002102.pub3. Cochrane Database Syst Rev. 2018. PMID: 30284239 Free PMC article.
References
-
- Cohen AM, Minsky BD, Schilsky RL. Cancer of the rectum. In: DeVita VT, Hellman S, Rosenberg SA, editor. Cancer: Principles and Practice of Oncology. 5. Philadelphia-New York: Lippincott-Raven; 1997. pp. 1197–1233.
-
- Mohiuddin M. Radiation: The preoperative adjuvant strategy. In: Cohen AM, Winawer SJ, editor. Cancer of the Colon, Rectum, and Anus. New York, McGraw-Hill; 1995. pp. 657–668.
-
- Figueredo A, Germond C, Taylor B, Maroun J, Agboola O, Wong R, Zwaal C, Micucci S, for the Gastrointestinal Cancer Disease Site Group Post-operative adjuvant radiotherapy or chemotherapy for resected stage II or III rectal cancer. Curr Oncol. 2000;7:37–51.
-
- Browman GP, Levine MN, Mohide EA, Hayward RSA, Pritchard KI, Gafni A, Laupacis A. The practice guidelines development cycle: a conceptual tool for practice guidelines development and implementation. J Clin Oncol. 1995;13:502–512. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources